Leaderboards/Cancer-related cognitive impairment studies

Cancer-related cognitive impairment studies

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Anthony Fernández-Castañeda
Stanford University
2
Lisa Crozier
University of Dundee
3
Anna C. Geraghty
Stanford University
4
K.P. Gabriel
Ludwig-Maximilians-Universität München
5
Emmie W. Koevoets
Utrecht University
6
Carl W. Belger
University of the Witwatersrand
7
Benjamin Ongnok
Mahidol University
8
Kimberly Demos-Davies
University of Minnesota
9
Boshi Wang
Zhejiang Chinese Medical University
10
Rei Kudo
National Cancer Centre Japan

Papers

1
Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
Cancer Cell|2024
47 cit.
2
Publication in Cell (2025) [39 citations, W4410314249]
Cell|2025
39 cit.
3
Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways
Molecular Neurobiology|2024
7 cit.
4
Impact of play restriction during the COVID-19 pandemic on mental well-being in children with a chronic condition
European Journal of Pediatrics|2024
2 cit.
5
Publication in Cancer Research (2024) [1 citation, W4396598718]
Cancer Research|2024
1 cit.
6
Longitudinal associations between chronic physical conditions, play behavior, and mental health problems in children
World Journal of Pediatrics|2025
1 cit.
7
Effect of physical exercise on white matter microstructure in chemotherapy-treated breast cancer patients: a randomized controlled trial (PAM study)
Brain Imaging and Behavior|2025
0 cit.
8
Publication in Clinical Cancer Research (2025) [W4411288351]
Clinical Cancer Research|2025
0 cit.
9
Development of an intelligent food nutrition recognition and nutrient intake assessment system in hospital settings
Frontiers in Nutrition|2026
0 cit.
10
Response to: Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells
EMBO Reports|2026
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Aiguo Xuan
Second Affiliated Hospital of Guangzhou Medical University
2
Martina Markes
Institute for Quality and Efficiency in Health Care
3
Antiño R. Allen
University of Arkansas Medical Center
4
Paige Green
National Cancer Institute
5
Shelli R. Kesler
The University of Texas at Austin
6
Mina Y. George
Ain Shams University
7
A. Shinde
Cedars-Sinai Medical Center
8
Munjal M. Acharya
University of California, Irvine
9
Idlir Licaj
Inserm
10
Götz Berberich
Unknown

Papers

1
Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
Frontiers in Psychology|2022
87 cit.
2
Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways
Inflammopharmacology|2023
56 cit.
3
Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
Inflammopharmacology|2023
53 cit.
4
Symptom Clusters Seen in Adult COVID-19 Recovery Clinic Care Seekers
Journal of General Internal Medicine|2022
43 cit.
5
Mettl1-mediated internal m7G methylation of Sptbn2 mRNA elicits neurogenesis and anti-alzheimer’s disease
Cell & Bioscience|2023
35 cit.
6
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
International Journal of Molecular Sciences|2022
32 cit.
7
Mettl3‐mediated m <sup>6</sup> A modification of Lrp2 facilitates neurogenesis through Ythdc2 and elicits antidepressant‐like effects
The FASEB Journal|2022
32 cit.
8
L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and Kidney/brain Axes
Journal of Neuroimmune Pharmacology|2023
30 cit.
9
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axes
Expert Opinion on Drug Delivery|2023
28 cit.
10
Design and evaluation of chrysin-loaded nanoemulsion against lithium/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative stress, microglia polarization, and AMPK/SIRT-1/PGC-1α pathway
Expert Opinion on Drug Delivery|2022
27 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Sanne B. Schagen
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
2
Ian F. Tannock
Princess Margaret Cancer Centre
3
Marı́a C. Carrillo
Alzheimer's Association
4
Kathryn H. Schmitz
Pittsburg State University
5
Patricia A. Ganz
Los Angeles County Department of Public Health
6
Yosuke Uchitomi
Jikei University School of Medicine
7
Andrew J. Saykin
Alzheimer’s Disease Neuroimaging Initiative
8
Paul B. Jacobsen
University of South Florida
9
Howard I. Scher
Memorial Sloan Kettering Cancer Center
10
D. Allan Butterfield
University of Kentucky

Papers

1
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
New England Journal of Medicine|2004
5.7k cit.
2
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
New England Journal of Medicine|2012
4.6k cit.
3
Abiraterone and Increased Survival in Metastatic Prostate Cancer
New England Journal of Medicine|2011
4.4k cit.
4
Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable
Medicine & Science in Sports & Exercise|2019
2.9k cit.
5
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
Medicine & Science in Sports & Exercise|2010
2.8k cit.
6
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
Journal of Clinical Oncology|2008
2.2k cit.
7
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Alzheimer s & Dementia|2024
2.2k cit.
8
Acid pH in tumors and its potential for therapeutic exploitation.
PubMed|1989
1.6k cit.
9
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Journal of Clinical Oncology|2016
1.6k cit.
10
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress
European Journal of Cancer|1994
1.6k cit.

Reagents for Cancer-related cognitive impairment studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 60

Talin-1 (C45F1) Rabbit Monoclonal Antibody

#4021$147,345
View Evidence →
Agilent/Dako

Cytokeratin 8, Low MW

#N1560
View Evidence →
Cell Signaling Technology

ProLong Gold Antifade Reagent with DAPI

#8961$279
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

CD97 (F1B5E) Rabbit Monoclonal Antibody

Cited in 11 papers
#42684$178,415
View Evidence →
MedChemExpressEvidence 71

Phospho-mTOR(Ser2448) Antibody (YA6075)

#HY-P86383
View Evidence →
Bio-RadEvidence 75

ChemiDoc MP Imaging System

#12003154
View Evidence →